跳至主要内容
临床试验/CTRI/2025/03/083378
CTRI/2025/03/083378尚未招募2 期

A RANDOMIZED OPEN CONTROLLED CLINICAL TRIAL TO STUDY THE EFFICACY OF BHARANGI NAGAR CHURNA WITH TANDULODAK IN TARUNI ASRUGDAR W.S.R. TO PUBERTY MENORRHAGIA

Dr Snehal Laxman Dongare1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2025年3月30日最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
To evaluate the efficacy of Bharangi Nagar churna with tandulodak in Taruni

研究概览

简要总结

This is randomised open controlled clinical trial to study the efficacy of bharangi nagar churna with tandulodak in taruni asrugdar in pubertal age group conducted at OPD no 8 and 15 of Yashwant dharmarth rugnalaya kodoli kolhapur. The result will be assess after 90 days of study.

研究设计

研究类型
Interventional
分配方式
Na
盲法
None

入排标准

年龄范围
13.00 Year(s) 至 19.00 Year(s)(—)
性别
Female

入选标准

  • 1 Age 13 to 19 years unmarried girls 2 Patients with complaints of excessive bleeding per vagina during menstruation either in amount or duration 3 Polymenorrhagia 4 Patient with Hb 9gper dl or more than 9g per dl.

排除标准

  • 1Known case of Endocrinal Disorder like Hypo or Hyperthyroidism PCOS 2 Known case of Bleeding Dyscrasias 3 Known case of Structural Abnormality in Genital Organ 4Known case of systemic disorders.

结局指标

主要结局

To evaluate the efficacy of Bharangi Nagar churna with tandulodak in Taruni

时间窗: 1st and 5th day of every cycle and after cessation of menses of every cycle for 3 consecutive cycles

Asrugdar W.S.R. to Puberty Menorrhagia.

时间窗: 1st and 5th day of every cycle and after cessation of menses of every cycle for 3 consecutive cycles

次要结局

  • 1. To reduce duration & amount of bleeding.(2. To assess improvement by parameters like PBAC.)

研究者

发起方
Dr Snehal Laxman Dongare
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Snehal Laxman Dongare

Yashwant Ayurvedic College Postgraduate Training and Research Centre Kodoli District Kolhapur

研究点 (1)

Loading locations...

相似试验